19-Oct-2010 - Southern Research Institute is acquiring BioCryst Pharmaceuticals’ bioanalytical laboratory assets and personnel in a move towards expanding its bioanalytical service offerings.
04-Oct-2010 - BioClinica shareholder Nicusa Capital is calling for the resignation of CEO Mark Weinstein, CFO Ted Kaminer and Chairman David Nowiki, after describing the firm’s corporate strategy as “defective.”
30-Sep-2010 - Covance has inked a 10-year strategic alliance, worth up to $2.2bn, with Sanofi-Aventis and acquired two European sites from the big pharma.
23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.
01-Sep-2010 - ImmunoSolv is merging with Grampian BioConsultants (GBC) and plans to accelerate development of the contract research business.
18-Aug-2010 - Encorium cut its operating loss to $775,000 in the second quarter despite posting a 17 per cent drop in total revenue.
16-Aug-2010 - Pre-clinical ADME contractor Cyprotex upbeat about 2010 despite drop in profit, citing new US opportunities post-Apredica acquisition.
09-Aug-2010 - Contract research organization (CRO) Lambda Therapeutic Research has acquired Biovail’s contract research division.
05-Aug-2010 - AMRI recorded a $6.0m (€4.6m) operating loss in the second quarter as restructuring charges and the lack of milestone payments offset contract service gains.
03-Aug-2010 - Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.
03-Aug-2010 - CRL and WuXi have both vowed to independently build their capabilities, to become integrated service providers, but reported mixed financial results.
30-Jul-2010 - Charles River Laboratories (CRL) has abandoned plans to buy Wuxi Pharmatech after the $1.6bn (€1.2bn) takeover failed to gain sufficient shareholder support.
29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact...
28-Jul-2010 - Icon reported a dip in operating income in the second quarter but an upturn in new business, and the cash to pursue M&A, make it reasonably positive about the future....
20-Jul-2010 - Encorium has bought Progenitor International Research, furthering efforts to fix its financial woes by focusing on vaccines, oncology and growth in emerging markets.
19-Jul-2010 - Major Charles River Laboratories (CRL) shareholder Jana Partners says Wuxi PharmaTech deal would generate inadequate returns, citing “industry” concerns about integration.
15-Jul-2010 - M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes...
15-Jul-2010 - CRL has said the WuXi buy could add up to $100m (€78m) in additional annual revenue and spoken of clients’ enthusiasm for the deal as its attempts to shore up...
12-Jul-2010 - Sanofi Aventis intends to sell two of its European research facilities to US-based contract research organisation (CRO) Covance.
05-Jul-2010 - Aptuit is to acquire GSK’s Italian R&D centre, take on its 500 employees and become part of the big pharma’s CRO network.
17-Jun-2010 - Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).
15-Jun-2010 - Bristol-Myers Squibb (B-MS) has inked deals with Icon and Parexel to support the large volume of clinical development work it expects to perform in coming years.
14-Jun-2010 - Patheon has posted a 12 per cent growth in operating profit in the second quarter and said there is “strong evidence” the business environment is improving.
11-Jun-2010 - Know your Lilly from your Lonza? Then test your industry knowledge against colleagues, peers and our community of readers by participating in our exclusive map-based quiz.
09-Jun-2010 - CRL shareholder Jana Partners has said the attempt to buy WuXi PharmaTech is the “wrong path” and it will vote against the deal.